newsfilter
← Latest News
GlobeNewswire·

XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB, TASE: XTLB.TA)) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets